1 year return (CAGR)
-18.66%
Mersana Therapeutics Inc Exchange (NASDAQ, USD)
MRSN
-
+0.04 (+0.14%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-40.95%
5 year return (CAGR)
-46.77%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
145.36M
Price/Sales
4.38
Ent value
211.20M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-2.73%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 28.90 |
| Daily high | 30.39 |
| Daily low | 28.78 |
| Daily Volume | 705K |
| 1y analyst estimate | 33.20 |
| Beta | 0.44 |
| EPS (TTM) | -14.05 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MRSN | S&P500 | |
| Current price drop from All-time high | -95.78% | -0.39% |
| Highest price drop | -99.05% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -66.11% | -10.68% |
| Avg time to new high | 61 days | 12 days |
| Max time to new high | 1263 days | 1805 days |
News
No items found